Abstract
Background International consortia have emerged as a common model to organise and fund large-scale, multi-disciplinary research in contemporary health and biomedical science. The diversity of participants, size and complexity of these consortia necessitates effective governance to achieve their research aims and societal impact. For health research consortia funded by the European Union, certain governance structures and processes have emerged out of convention. However, there is limited scientific evidence to support their use, and little is known about consortia participants’ perspectives on how governance structures could be improved to better serve the implementation of research. In this paper, we present a protocol for a qualitative study to explore the perspectives of participants in European Union-funded health research consortia on the value of governance structures and how they might be improved.
Methods and analysis We will conduct a qualitative study using in-depth interviews with participants in health research consortia funded by the European Union. We will recruit participants following a purposeful sampling approach, and recruitment will continue until saturation is reached. During in-depth interviews, we will ask participants about how the governance of consortia is structured and what is working well or poorly about those governance structures from their perspective. We will draw on design thinking methods to help participants to ideate improvements in governance structures. Data will be analysed using a thematic analysis approach.
Discussion Findings from this study will provide valuable evidence for developing and formulating governance structures for health research consortia. The findings of this work may also contribute to guidelines for consortium proposal submissions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study received ethics approval from the Ethics Committee of the Medical Faculty of Heidelberg University on 13.09.2023 [reference number S-516/2023]. The study is conducted under the General Data Protection Regulation. All participants will be provided with a participant information sheet explaining the study and what their participation would involve. Participants will sign an informed consent form before participating.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
